This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monsanto's Stock Is Still a Long-Term Growth Story

NEW YORK (TheStreet) -- Shares of agriculture giant Monsanto (MON - Get Report), which are near their 52-week high, have been growing like weeds, closing Monday at $122.10, up nearly 5% for the year to date.

Although the YTD performance is modest, you'll be hard-pressed to find a better performer over the past four years. During that span, Monsanto stock has bloomed well over 160% compared to the Dow's 75% gain.

Monsanto will report third-quarter earnings Wednesday. With management operating on all cylinders, I would not be in a rush to sell the stock here, especially since management recently backed its full-year outlook, saying it expects to post a smaller loss in the fourth quarter compared to previous years.

Remarkably, the stock has risen amid consumer protests over Monsanto's genetically modified seeds. These issues have raised debates about genetically modified organisms (GMO) and the extent to which they should be disclosed on food labels.

With the company involved in so much controversy, investors want to know if Monsanto is still a good stock to own, especially after such a strong four-year run. I wouldn't sell just yet, however. There's still potentially 15% more growth left in these shares -- and that may be conservative.

Consider that when compared to rivals Syngenta (SYT) and DuPont (DD), Monsanto already enjoys a strong market position in areas like corn and soybeans. This is due (in part) to Monsanto's Roundup Ready and Intacta traits, which allow farmers to effectively control weeds while preserving the safety of their crops.

Now there are signs Monsanto's growth potential may be even better. In the most recent quarter, Monsanto soybean sales jumped 21%. This was preceded by a 16% jump in the January quarter.

This means that Monsanto's core seed operations are staring to do the heavy lifting. Investors should be encouraged by this. Combined with the dominant performance of the agricultural productivity business, which includes the aforementioned herbicides such as Roundup, investors can expect a sharp upward move in Monsanto's profits in the next 12 to 18 months. This should bode well for the stock.

Part of the optimism has to do with a recent report from the U.S. Department of Agriculture that projects a 6% jump in soybean acreage for 2014, which would be a record at 81.5 million.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MON $95.43 0.00%
AAPL $117.81 0.00%
FB $105.45 0.00%
GOOG $750.26 0.00%
TSLA $231.61 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs